|
2021
|
Invention
|
Fap binding molecules and uses thereof.
Disclosed herein are fibroblast activation protein (FAP)... |
|
|
Invention
|
Epcam binding molecules and uses thereof.
Disclosed herein are epithelial cell adhesion molecule... |
|
|
Invention
|
Cea6 binding molecules and uses thereof.
Disclosed herein are carcinoembryonic antigen 6 (CEA6)-... |
|
|
Invention
|
Mesothelin binding molecules and uses thereof.
Disclosed herein are mesothelin (MSLN)-specific b... |
|
|
Invention
|
Cea5 binding molecules and uses thereof. Disclosed herein are carcinoembryonic antigen 5 (CEA5)-s... |
|
|
Invention
|
Gpc3 binding molecules and uses thereof. Disclosed herein are glypican-3 (GPC3)-specific binding ... |
|
|
Invention
|
Mesothelin binding molecules and uses thereof. Disclosed herein are mesothelin (MSLN)-specific bi... |
|
|
Invention
|
Muc1 binding molecules and uses thereof. Disclosed herein are mucin-1 (MUC1)-specific binding pol... |
|
|
Invention
|
Cea6 binding molecules and uses thereof. Disclosed herein are carcinoembryonic antigen 6 (CEA6)-s... |
|
|
Invention
|
Fap binding molecules and uses thereof. Disclosed herein are fibroblast activation protein (FAP)-... |
|
|
Invention
|
Epcam binding molecules and uses thereof. Disclosed herein are epithelial cell adhesion molecule ... |
|
|
Invention
|
Compounds as mrgprx2 antagonists. Provided are compounds that are antagonists of MRGPRX2 and are ... |
|
|
Invention
|
Compounds as ras inhibitors and uses thereof. The present disclosure relates generally to compoun... |
|
|
P/S
|
Scientific Research and development of cell therapies, namely, chimeric antigen receptor T-cells ... |
|
2020
|
Invention
|
Compounds as cd73 inhibitors.
Provided herein are the compounds that are inhibitors of CD73 and ... |
|
|
Invention
|
Compounds as cd73 inhibitors. Provided herein are the compounds that are inhibitors of CD73 and a... |
|
|
Invention
|
Cd73 inhibitors.
The present disclosure relates generally to compounds that are inhibitors of CD... |
|
|
Invention
|
Cd73 inhibitors.
Disclosed are compounds that arc inhibitors of CD73 and arc useful in treating ... |
|
|
Invention
|
Cd73 inhibitors. Disclosed are compounds that are inhibitors of CD73 and are useful in treating C... |
|
|
Invention
|
Cd73 inhibitors. The present disclosure relates generally to compounds that are inhibitors of CD7... |
|
|
Invention
|
Aromatic derivatives, preparation methods, and medical uses thereof. The present disclosure relat... |
|
2019
|
Invention
|
Imidazotriazine derivatives as cd73 inhibitors. The present disclosure relates generally to imida... |
|
|
Invention
|
Quinazoline derivatives as cd73 inhibitors. Provided are quinazoline derivatives that are inhibit... |
|
2018
|
Invention
|
Aromatic derivative, preparation method for same, and medical applications thereof. An aromatic d... |
|
|
Invention
|
Aromatic derivative, preparation method for same, and medical applications thereof. The present i... |
|
2017
|
Invention
|
Aromatic ether derivative, preparation method therefor, and medical applications thereof. The pre... |
